Engert, Andreas
Andreas Engert
Engert, Andreas, 1972-....
VIAF ID: 274836537 (Personal)
Permalink: http://viaf.org/viaf/274836537
Preferred Forms
- 100 0 _ ‡a Andreas Engert
-
- 100 1 _ ‡a Engert, Andreas
-
- 100 1 _ ‡a Engert, Andreas
- 100 1 _ ‡a Engert, Andreas, ‡d 1972-....
4xx's: Alternate Name Forms (2)
5xx's: Related Names (3)
- 551 _ _ ‡a Köln ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a Universitätsklinikum Köln ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Universitätsklinikum Köln ‡b Klinik I für Innere Medizin ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma | |
Ausländische Kapitalgesellschaften im deutschen Recht | |
Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study | |
Business law and the transition to a net zero economy : a handbook | |
Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma | |
Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation | |
Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function | |
Effects of all-trans retinoic acid | |
Erythropoietin or darbepoetin for patients with cancer | |
Etablierte und innovative Wege in der Hämatologie immunonkologische und zielgerichtete Therapien bei dem multiplen Myelom, der CML und dem Hodgkin-Lymphom | |
Europäisches Privat- und Wirtschaftsrecht | |
Europarechtliche Bezüge des Privatrechts | |
The European Hematology Association Roadmap for European Hematology Research: a consensus document | |
Experimentelle zytostatische Behandlung menschlicher Tumorzellen in der Nude-Maus: bietet das intrakranielle Testsystem eine Alternative? | |
First-line stem cell transplantation from related donors compared to immunosuppressive treatment for acquired severe aplastic anaemia | |
Gezielte Früherkennung und risikoadaptierte Therapie | |
Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma | |
Hodgkin Lymphoma : A Comprehensive Update on Diagnostics and Clinics | |
Hodgkin lymphoma-derived extracellular vesicles change the secretome of fibroblasts toward a CAF phenotype | |
Hodgkin's lymphoma, 2007: | |
Hypomethylating agents for adult patients with acute myeloid leukaemia | |
Intravenous immunoglobulins for the treatment of infections in patients with haematological cancers | |
Low dose cytarabine monotherapy for myelodysplastic syndromes | |
Mindfulness-based stress reduction for women diagnosed with breast cancer | |
Monoklonale Antikörper in der Leukämietherapie | |
Myeloablative high-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults | |
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival | |
Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma | |
Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy | |
Purine analogues plus cyclophosphamide versus purine analogues alone for first-line therapy of patients with chronic lymphocytic leukaemia | |
Radiotherapy in the GHSG HD 16 and HD 17 trials – quality assurance and dosimetric analysis for Hodgkin lymphoma in the modern era | |
The role of additional radiotherapy for primary central nervous system lymphoma (PCNSL) | |
Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doors | |
Therapieergebnisse beim rezidivierten nodulär Lymphozyten-prädominanten Hodgkin Lymphom | |
Thrombopoietin mimetics for patients with myelodysplastic syndromes | |
time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma | |
Yoga in addition to standard care for patients with haematological malignancies |